All Viruses articles – Page 20
-
NewsRNA viruses may differentially shape carbon recycling in the ocean
A new study has uncovered that certain ocean viruses—specifically RNA viruses—may disrupt how carbon and nutrients are recycled in the ocean, potentially altering the global carbon cycle.
-
NewsSwiss genome of the 1918 influenza virus reconstructed
Researchers have decoded the genome of the virus responsible for the 1918–1920 influenza pandemic in Switzerland, revealing that it had already developed key adaptations to humans at the outset of the deadliest influenza pandemic in history.
-
NewsH5N1 influenza outbreaks in US cattle likely triggered by ‘milk-stealing’ behavior of lactating cows
As of June 2025, H5N1 outbreaks have been reported on more than 1,070 dairy farms across 17 US states. Researchers have solved the mystery of how H5N1 virus enters the mammary glands of dairy cows, and provide a strategy on how to control the disease.
-
NewsNew study finds evidence of hepatitis C virus in cells lining human brain
Observational studies of psychiatric diseases such as schizophrenia and bipolar disorder have long tied viral infections with behavioral symptoms in these disorders. Scientists have now found a connection in the form of hepatitis C virus in the human brain’s choroid plexus.
-
NewsEmerging viral threats combatted by a potent new dual lipid kinase inhibitor
Lipid kinases play a critical role in cell signalling and membrane trafficking by phosphorylating lipid molecules in the body. The inhibition of two of these lipid kinases, PIKfyve and PIP4K2C, could be beneficial in the treatment of diseases, particularly emerging viruses.
-
NewsScientists discover compounds that help cells fight a wide range of viruses
Researchers have identified compounds that can fight off viral infection by activating a defense pathway inside host cells. These compounds, they believe, could be used as antiviral drugs that work against not just one but any kind of virus.
-
NewsLong Covid lessons: New cell therapy boosts immune recovery in cats with severe coronavirus
Feline infectious peritonitis is a serious and historically fatal disease in cats caused by a coronavirus. Scientists have found that mesenchymal stromal cells, or MSC therapy, in combination with antiviral drugs, helped cats’ immune systems recover and reduced systemic inflammation.
-
NewsScientist’s cat on the hunt helps to discover a second new virus
Pepper, the pet cat who made headlines last year for his role in the discovery of the first jeilongvirus found in the U.S., is at it again. This time, his hunting prowess contributed to the identification of a new strain of orthoreovirus.
-
NewsTiny chip speeds up antibody mapping for faster vaccine design
By analyzing just a drop of blood, this microchip gives researchers quicker-than-ever insight into how a person’s antibodies are interacting with a virus or other pathogen.
-
NewsAnti-cancer drug shows promise against tick-borne virus
Researchers have offered fresh insights into how Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), an emerging tick-borne pathogen, opposes host apoptosis signaling.
-
NewsHepatitis C treatment is not reaching some at-risk populations, studies show
Studies reveal that two vulnerable populations — children and recently pregnant women — face disparities in access to treatment for hepatitis C infection. Without treatment, they are at risk of long-term adverse health outcomes such as cirrhosis, liver cancer and death.
-
NewsCohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer
Denmark has been offering free vaccination against human papillomavirus (HPV) to girls since 2008. New data show vaccination has effectively reduced infections with cancerogenic HPV 16/18 types covered by the vaccine, indicating population immunity.
-
NewsScientists ID new drug target for treating cancer and viral infections
An international team of researchers has identified a molecular mechanism that regulates the activity of N-myristoyltransferases, enzymes that ensure the proteins’ function by chemically modifying them during their production.
-
NewsChameleon plant polysccharide targets acute pneumonia with H1N1 and MRSA coinfection
A new study discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation.
-
NewsGlobal trends and cross-country inequalities of acute hepatitis E in the elderly, 1990–2021
Acute hepatitis E (AHE) in the elderly can lead to severe complications including liver failure and mortality. A new study aimed to assess the trends and health inequalities of AHE among the elderly over the past three decades, and predict its changes by 2030.
-
NewsStructure of tick-borne virus revealed at atomic resolution for the first time
One emerging tick-borne virus in North America is the Powassan virus (POWV), which can cause encephalitis, seizures, paralysis and coma. Rates of POWV infections have increased in recent years and currently, there are no treatments available.
-
NewsSummer travel ‘will increase the spread of measles,’ expert says
The number of measles cases in the U.S. has reached its highest point in 33 years, and outbreaks are expected to continue, especially amid national and international travel.
-
NewsFrom COVID to cancer, new at-home ‘coffee-ring’ test spots disease with startling accuracy
A new, low-cost biosensing technology could make rapid at-home tests up to 100 times more sensitive to viruses like COVID-19. The diagnostic could expand rapid screening to other life-threatening conditions like prostate cancer and sepsis as well.
-
NewsScientists investigate gut microbiota in elderly patients with acute hepatitis E infection
A new study of the impact of hepatitis E virus infection on the gut microbiota identifies a bacterial species as a potential biomarker for disease outcomes.
-
NewsVanderbilt and Parse Biosciences collaborate on new measles treatment
Vanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a new treatment to help unvaccinated measles victims, as the U.S. measles outbreak has now reached its highest case count in 30 years.